Novartis

2136 articles with Novartis

• U.S. Approves Novartis AG's Tekturna HCT

  1/21/2008

• Novartis AG Steps Back from Developing Galvus in the United States

  1/17/2008

• Novartis AG Achieves Record Results in 2007 Underscoring Benefits of Strategic Healthcare Portfolio

  1/17/2008

• Avalon Pharmaceuticals Announces the Initiation of Compound Characterization Phase in Drug Discovery Collaboration

  1/14/2008

• Watson Pharmaceuticals, Inc. and Novartis Pharmaceuticals Corporation Settle Lawsuit Over Exelon(R) Patent Litigation

  12/7/2007

• Bayer AG (Jobs) Up On Fresh Talk of Novartis AG Interest Say Traders

  12/4/2007

• Novartis Pharmaceuticals Corporation New Preclinical Data Suggests FTY720 May Repair or Reduce Damage Caused by Multiple Sclerosis Through a Direct Effect in the Brain

  10/12/2007

• Speedel Holding AG And Novartis Pharmaceuticals Corporation Win The Wall Street Journal Gold Award

  9/24/2007

• Vernalis PLC Gets 1.5 Million stg Milestone Payment from Novartis Pharmaceuticals Corporation for Oncology Product

  9/4/2007

• Human Genome Sciences, Inc. Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule

  8/28/2007

• Human Genome Sciences, Inc. Announces $40 Million Milestone Payment Related to Albuferon(R) Development

  8/28/2007

• Novartis Pharmaceuticals Corporation's Reclast(R) Receives FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis

  8/20/2007

• Multiple Myeloma Research Consortium Partners with Novartis Pharmaceuticals Corporation to Advance Phase II Study of Deacetylase Inhibitor

  8/15/2007

• Novartis Pharmaceuticals Corporation Pursues Legal Actions to Defend Intellectual Property Rights for High Blood Pressure Medicine Lotrel Following US Court Ruling

  5/22/2007

• Novartis Pharmaceuticals Corporation Release: Positive Results Prompt US National Cancer Institute to Make Gleevec(R) Available To Patients in Post-Surgical GIST Study

  4/13/2007

• Novartis Pharmaceuticals Corporation Release: Tekturna(R), First New Type of High Blood Pressure Medicine in a Decade, Provides Additional Blood Pressure Reduction When Used With Diovan(R)

  3/26/2007

• The Day In Review: Novartis Pharmaceuticals Corporation Gets Approval For Hypertensive Drug Tekturna

  3/6/2007

• Novartis Pharmaceuticals Corporation (Jobs) Boosted as U.S. Approves TekTurna Drug

  3/6/2007

• Immunicon Corporation Awarded Research Services And Laboratory Master Services Agreements From Novartis Pharmaceuticals Corporation

  1/29/2007

• Novartis Pharmaceuticals Corporation Strategic Healthcare Portfolio Drives Sustained Strong Performance With Record Full-Year Results In 2006

  1/18/2007